comparemela.com

Latest Breaking News On - Zegbeh jallah - Page 2 : comparemela.com

Immunic Inc (IMUX) CEO Daniel Vitt on Q1 2022 Results - Earnings Call Transcript

Immunic Inc. (NASDAQ:NASDAQ:IMUX) Q1 2022 Earnings Conference Call May 10, 2022, 8:00 AM ET Company Participants Daniel Vitt – Chief Executive officer, President & Director Glenn Whaley.

New zealandMatthew kaplanAndreas argyridesPiper sandlerDaniel vittZegbeh jallahBoobalan pachaiyappanJessica breuGlenn whaleyThomas smithYasmeen rahimiLautenbach tallmannCompany participantsDeco congressImmunic incConference call may

Ocugen, Inc (OCGN) CEO Shankar Musunuri on Q1 2022 Results - Earnings Call Transcript

Ocugen, Inc. (NASDAQ:NASDAQ:OCGN) Q1 2022 Earnings Conference Call May 06, 2022 08:30 AM ET Company Participants Ken Inchausti - Head, Investor Relations & Communications Shankar.

United statesDaniel kathalynasSwayampakula ramakanthJessica crespoShankar musunuriKen inchaustiImran khanZegbeh jallahCompany participantsHealth net solutionsCommunications for ocugenInvestor relations communicationsWorld health organizationOcugen incWorld vaccine congressExchange commission

Ocugen, Inc (OCGN) Q1 2022 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2022.

United statesJess crespoJessica crespoShankar musunuriKen inchaustiZegbeh jallahExchange commissionWorld health organizationOcugen incWorld vaccine congressInvestor relationsRisk factorsChief executiveBharat biotechEmergency use authorizationAccounting afficer

GlycoMimetics, Inc (GLYC) CEO Harout Semerjian on Q1 2022 Results - Earnings Call Transcript

GlycoMimetics, Inc. (NASDAQ:NASDAQ:GLYC) Q1 2022 Results Conference Call April 28, 2022 08:30 AM ET Company Participants Shari Annes - IR Harout Semerjian - CEO Brian Hahn - CFO Armand.

New yorkUnited statesHarout semerjianShari annesArmand girardBrian hahnRafael pharmaRed whiteZegbeh jallahCompany participantsNational cancer instituteGlycomimetics incInvestor relations group of glycomimeticsConference call aprilInvestor relations groupInvestor relations

GlycoMimetics (GLYC) Q1 2022 Earnings Call Transcript

GLYC earnings call for the period ending March 31, 2022.

New yorkUnited statesHarout semerjianShari annesArmand girardBrian hahnRafael pharmaRed whiteZegbeh jallahNational cancer instituteCompany analystNational cancerBoris peakerRoger songGlobal investment conferenceJefferies healthcare conference

vimarsana © 2020. All Rights Reserved.